Scoop has an Ethical Paywall
Licence needed for work use Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

NZ Deserves First Class Health Treatment

New Zealanders Deserve First Class Health Treatment

“New Zealanders deserve first class health treatment not third world” says Arthritis New Zealand after New Zealand came last in a comparison of 14 developed nations on their use of selected medicines.

The study showed New Zealand was far below Australia in the tallied medicine use for rheumatoid arthritis.

Rheumatoid arthritis is the second most common form of arthritis, and there is approximately 40,000 New Zealanders suffering from this unpredictable disease. It can occur at any age and it affects women three times more often than men.

Sandra Kirby, Chief Executive of Arthritis New Zealand said: ”Coming last in this study should be the wake-up call the Government needs to start investing in more medicines being made available within New Zealand to treat debilitating diseases like arthritis.”

“We can’t continue to use excuses like the size of our country to not invest for example in a second biologic option for arthritis sufferers. Is it not creating a false economy if we save on the cost of employing Rheumatologists and medicines but in return have a sicker population that end up using more health and welfare resources creating a bigger burden to our economy?”

“Over 25,000 New Zealanders will not work in 2010 due to arthritis costing around $1.48 billion in lost productivity in 2010. By investing in more health services we could cut this cost dramatically.”

ENDS

Advertisement - scroll to continue reading

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.